Galmed Pharmaceuticals Ltd. logo

GLMDGalmed Pharmaceuticals Ltd.

GLMD Stock Price, Valuation & Chart | Galmed Pharmaceuticals Ltd.

Compare

GLMD Historical price chart

GLMD Key Stats

Fair Value
Disclaimer

Disclaimer: This fair value estimate is for informational purposes only and should not be considered as investment advice. Fair value calculations are based on DCF (Discounted Cash Flow), P/E Multiple, and P/S Multiple models and assumptions that may not reflect actual market conditions. Always conduct your own research and consult with a financial advisor before making investment decisions.

Market Capitalization4.25M
PE Ratio-0.98
EPS-4.2
Trading Volume14.41K
Today's High/Low4.22/4.0
Dividend Yield0.00
52 Week High/Low13.2/3.29
Shares Outstanding1.03M
GLMD Financial Statement
GLMD Analyst ratings
GLMD Analysis & performance metrics

GLMD Company profile

Galmed Pharmaceuticals Ltd., a clinical-stage biopharmaceutical company, focuses on the development of therapeutics for the treatment of liver diseases. It develops Aramchol,…

GLMD Management team

Management
Allen BaharaffCEO
Co-Founder, President, Chief Executive Officer & Chairman
Tali Gorfine
Medical Consultant
Doron CohenCFO
Chief Financial Officer
Liat Hayardeny MBA, Ph.D.
Chief Scientific Officer
Yohai Stenzler CPA
Chief Accounting Officer
Guy NehemyaCOO
Chief Operating Officer & Data Protection Officer
Total 6 executives

GLMD Frequently asked questions

What is Galmed Pharmaceuticals Ltd. (GLMD) Stock Price?

Current stock price of Galmed Pharmaceuticals Ltd. (GLMD) stock is $4.120. The stock price is +4.94% higher in the session. The intraday range can be seen from this page. Volume of Galmed Pharmaceuticals Ltd. (GLMD) stock is 14.41K.

Last updated at 02 Sept 2026, 08:00 pm.

Why is the Galmed Pharmaceuticals Ltd. (GLMD) stock price going up or down today?

The stock price of Galmed Pharmaceuticals Ltd. (GLMD) can change with earnings, company news, and overall market sentiment. Galmed Pharmaceuticals Ltd. operates in the Healthcare / Biotechnology market, so sector-wide moves can also affect the share price. Use the live price, percentage change, and volume on this page to judge whether a move looks meaningful.

Is the Galmed Pharmaceuticals Ltd. stock expensive at its current price?

Whether Galmed Pharmaceuticals Ltd. looks expensive depends on valuation metrics versus its growth outlook. The P/E ratio shown for GLMD on this page is -0.98. EPS on this page is -4.20. Compare those figures with peers and growth expectations before deciding if the current Galmed Pharmaceuticals Ltd. price is justified.

How has the stock price of Galmed Pharmaceuticals Ltd. (GLMD) performed historically?

Historical performance for Galmed Pharmaceuticals Ltd. (GLMD) is shown on the price chart on this page. Review multi-period moves alongside volume to see how GLMD reacted to past earnings and market events.

Should I buy Galmed Pharmaceuticals Ltd. (GLMD) stock, at this price?

Buying Galmed Pharmaceuticals Ltd. (GLMD) depends on your risk tolerance, time horizon, and portfolio needs. As a Healthcare name, weigh the live quote, key stats, and valuation links on this page rather than a single price point.